life science medical News
-
Noleus Wins Audience Choice at MedTech Innovator Pitch Event
Noleus Technologies won the audience choice award at the MedTech Innovator Houston Pitch Event. The event was hosted at the Johnson and Johnson Innovation JLABS@TMC event space. According to the MedTech Innovator website, these events "feature pitches from best-in-class medical device, diagnostic, and digital health companies vying for a spot in the 2018 program." Judging from local experts in ...
-
PerkinElmer Appoints Aaron Geist as Vice President, Business Development
Extensive Health Sciences Industry Experience Will Drive Company's Business Development Strategy BOSTON - Jan. 19, 2006 - PerkinElmer, Inc. (NYSE: PKI), a global technology leader in the health sciences and photonics markets, today announced the appointment of Dr. Aaron Geist as Vice President, Business Development for the Company. Dr. Geist will be responsible for developing ...
-
Benefits of publishing with us
UCL is committed to using its position and unique set of strengths to develop and disseminate original knowledge, not only for its own inherent value but also to address the significant challenges facing the world today and those that will arise in the future. Drawing on UCL’s founding values, we want to stimulate disruptive thinking across and beyond the university to showcase radical and ...
By UCL Press
-
Third Pole Therapeutics Names Bill Athenson New CEO
Third Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, has named seasoned healthcare executive Bill Athenson as its new Chief Executive Officer, the company announced today. David Zapol, Third Pole’s founding CEO, will continue providing strategic counsel to Third Pole. Athenson joins Third Pole building on the ...
-
Israeli firm says micro-pancreas to `cure` diabetes ready for UK trials
Exclusive: hopes testing can begin in 2021 on product intended to free people of need for insulin injections An Israeli company claiming to have created a tiny micro-pancreas that can “cure” diabetes for millions of people has said it will submit a request next month for human clinical trials in the UK. Betalin Therapeutics said its “bio-artificial” pancreas aims to ...
-
Edinburgh Molecular Imaging Ltd appoints new Chairman
The Board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans CBE CEng as non-executive Chairman with effect from 31st August 2015. In an industrial career spanning 35 years John held senior international leadership positions in global companies including Smith & Nephew, Bristol Myers Squibb, Johnson & Johnson and Amersham plc (now GE ...
-
Announcing a New Leadership Team at Vave Health
Vave Health, the innovative Silicon Valley startup democratizing medical care through handheld wireless ultrasound, today announced the appointment of a new leadership team to support the company’s accelerated growth in the medical imaging market. David Garner, a veteran of point-of-care ultrasound and previous vice president at Butterfly Network, will be taking on the role of Chief ...
-
Alfa Chemistry: Custom Design Takes Organs-On-Chips to the Next Level
In a groundbreaking move to revolutionize the field of biomedical research, Alfa Chemistry recently announced the launch of its highly anticipated custom organs-on-chips service. This cutting-edge technology provides scientists and researchers with an innovative platform to study human organs in a way that was previously impossible, promising to accelerate drug discovery, reduce the need for ...
-
Signifier Medical Technologies Announces $49MM Purchase of Existing Shares by Waha Capital, Angelus Sano Ventures and Segulah Medical Acceleration
Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announced that Waha Capital PJSC (“Waha Capital”), Angelus Sano Fund L.P. (“Angelus”), Segulah Medical Acceleration AB (“Segulah Medical”) and certain other individual investors have collectively invested approximately $49 ...
-
Strong Team in Development of Tendon Product
In 2011, Erik Kubiak, M.D., an orthopaedic trauma and adult reconstruction surgeon and Associate Professor of Orthopaedic Surgery at the University of Utah, co-founded CoNextions Medical to treat tendon repairs differently than traditional, suture-based methods. Earlier this year, the company received the Utah Innovation Award in the Life Sciences – Medical Device category for its ...
-
Adagio Medical Raises $42.5 Million In Series E Financing
Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the intelligent Continuous Lesion Ablation System (iCLAS), today announced that it has closed a $42.5 million Series E equity financing. Proceeds from the financing will be used to support the ongoing iCLAS Investigational Device Exemption (IDE) trial, ...
-
PixCell Medical Announces Acquisition by Soulbrain Holdings
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Soulbrain Holdings has acquired all controlling PixCell shares, as well as investing in the company, making Soulbrain the majority shareholder of PixCell Medical. The acquisition of PixCell aligns with Soulbrain's recent strategic transition into the healthcare and in-vitro diagnostics space. ...
-
Capricor Therapeutics Appoints Xavier Avat as Chief Business Officer
Capricor Expands Senior Management Team to Build Commercial Strategy for Lead Asset, CAP-1002, and Further Develop Partnering Strategy for Proprietary Exosome Platform Formerly at Edwards Lifesciences, Gilead and Genentech, Mr. Avat Brings Over 25 Years of Business and Commercial Strategy Experience to Capricor Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company focused on the ...
-
Optimizing Monoclonal Antibody Production: Temperature And Osmolality’s Impact, Upcoming Webinar Hosted By Xtalks
In this free webinar sponsored by Advanced Instruments, gain insights into advances in monoclonal antibody production technology and manufacturing strategies. Attendees will learn why temperature and osmolality in cell culture are critical parameters affecting cell growth, viability and the concentration of HCPs in the supernatant. The featured speaker will discuss how temperature and osmolality ...
-
ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announces that the United States Patent and Trademark Office (“USPTO”) has issued an Issue Notification for U.S. Patent Number 10010441 entitled “Gastric Restriction Device for Treating Obesity,” which covers a patent application ...
-
Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems
Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has added two life science industry veterans to its senior management team. Roger Schaller has been appointed Executive Vice President (EVP) of Commercial ...
-
Hyalex Welcomes Chris Cain as VP of Clinical and Regulatory Affairs
Hyalex welcomes executive team member, Chris Cain, serving as Vice President of Clinical and Regulatory Affairs. Chris joins the Hyalex team with an impressive background in leading numerous clinical trials of implanted medical devices and taking innovative technologies through US PMA and international regulatory approvals. Chris provides the experience necessary to bring the HYALEX® ...
-
Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker “HYPR” on the Nasdaq Global Market
Business combination results in over $160 million in gross cash proceeds to Hyperfine Funds to catalyze commercial expansion of the world’s first FDA-cleared portable MRI systemTM and additional organic growth initiatives Hyperfine to begin trading on Nasdaq under ticker “HYPR” Hyperfine Inc., the groundbreaking medical device company that created Swoop®, the ...
By Hyperfine
-
ReShape Lifesciences Technologies to be Featured at Minimally Invasive Surgery Symposium
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that the Company and its products will be discussed during the Metabolic and Bariatric Sessions of the Minimally Invasive Surgery Symposium (MISS) taking place in Las Vegas from March 6-9, 2018. Details of the presentations are as follows: Friday, ...
-
ReShape Lifesciences Announces Stocking Order from Medical Supplier in Dubai
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases announced today that it has received a significant order for its ReShape® Integrated Dual Balloon System from Al Zahrawi Medical a healthcare focused company specializing in medical, surgical, diagnostic and analytical lab and nuclear medicine supplies with ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you